Windlas Biotech Ltd.

NSE: WINDLAS | BSE: 543329

Windlas Biotech Live Share Price Today, Share Analysis and Chart

Slowing Down Stock

In 1 Starfolio Basket

Iran war impact

The impact of the Iran-Israel conflict on Windlas Biotech Ltd. is classified as Neutral. The company is primarily a domestic player in the Indian pharmaceutical market, with negligible direct exposure to the Middle East conflict zones. ### 1....

727.30 8.95 (1.25%)

New 52W Low in past week

17,985

NSE+BSE Volume

NSE 20 Mar, 2026 3:40 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

Medium Financial Strength

- / 100

Mid Valuation

- / 100

Technically Bearish

29.1 / 100

Slowing Down Stock These stocks have medium financials and valuations, but weak momentum indicating decreasing investor interest View Similar Embed DVM

No estimates available

Windlas Biotech Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

VOTE: Is Windlas Biotech Ltd. worth buying?

70 Votes:

Buy 85.71%

Sell 11.43%

Hold 2.86%